Vitamin E in Early Childhood Tied to Lower ALT Levels Later

This article originally appeared here.
Share this content:
Vitamin E in Early Childhood Tied to Lower ALT Levels Later
Vitamin E in Early Childhood Tied to Lower ALT Levels Later

MONDAY, Nov. 27, 2017 (HealthDay News) -- Higher early childhood intake of alpha-tocopherol is associated with lower odds of elevated mid-childhood alanine aminotransferase (ALT) levels, according to a study published online Nov. 9 in Hepatology.

Jennifer A. Woo Baidal, M.D., M.P.H., from the Columbia University Medical Center in New York City, and colleagues evaluated the extent to which vitamin E (alpha-tocopherol) intake early in childhood is associated with ALT levels later in childhood. Mothers of 528 children completed a validated food frequency questionnaire during early childhood visits (median 3.1 years), while blood and anthropometric data were collected at a mid-childhood visit (median 7.6 years).

The researchers found that mean alpha-tocopherol intake was 3.7 mg/day in early childhood. Mean body mass index (BMI) z-score was 0.41 units and 22 percent of children had an elevated ALT level at the mid-childhood evaluation. Multivariable-adjusted logistic regression models showed that there were lower odds of elevated mid-childhood ALT (adjusted odds ratio, 0.62; 95 percent confidence interval, 0.39 to 0.99) for quartiles 2 through 4 versus the lowest quartile in children with higher early childhood vitamin E intake. Even after accounting for early childhood diet, the trend persisted (adjusted odds ratio, 0.62; 95 percent confidence interval, 0.36 to 1.08) and was strengthened after accounting for mid-childhood BMI z-score (adjusted odds ratio, 0.56; 95 percent confidence interval, 0.32 to 0.99).

"Our findings suggest that modifiable risk factors, specifically intake of vitamin E, should be considered in future interventions to identify approaches to prevent pediatric nonalcoholic fatty liver disease," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

ASH: Anti-CD19 CAR T-Cell Tx Beneficial in B-Cell Lymphomas

ASH: Anti-CD19 CAR T-Cell Tx Beneficial in B-Cell ...

Second study shows benefit in relapsed or refractory B-cell lymphoma, follicular lymphoma

ASH: AAVD Beats ABVD for Advanced Hodgkin's Lymphoma

ASH: A+AVD Beats ABVD for Advanced Hodgkin's Lymphoma

Lower combined risk of progression, death, or noncomplete response with A+AVD

ASH: High-Dose Gene Transfer Beneficial in Severe Hemophilia A

ASH: High-Dose Gene Transfer Beneficial in Severe Hemophilia ...

Factor VIII gene transfer tied to sustained normalization of factor VIII activity levels

is free, fast, and customized just for you!

Already a member?

Sign In Now »